Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000107

Director sold 1,666 shares at an average $29.84 ($49,709)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
SATO VICKI L Director 2023-06-28 Sale 10b5-1 −552 $29.55 $16,312 135,817 D
SATO VICKI L Director 2023-06-28 Sale 10b5-1 −1,114 $29.98 $33,398 134,703 D
Open-market sales · 1,666 sh · avg $29.84 · $49,709
Loading xslF345X04/wk-form4_1688160091.xml…